---

Knowledge, attitude & perceptions of 3rd term medical students towards clinical trials in a medical college in southern India

---

Original Article

Author Details : Priyadarshini M. Deodurg, Harish G. Bagewadi, B.V. Patil, Asha P. Dass

Volume : 4, Issue : 3, Year : 2017

Article Page : 125-129

Suggest article by email

Get Permission

---

Abstract

Aim of the study: The present Study was performed to know the awareness of clinical trials and to assess the effectiveness of an educational intervention.
Materials and Method: This was a questionnaire-based pre- and post-test educational interventional study. Handouts which contain information about clinical trials were given one week before the study. A pre-validated 20-point questionnaire comprising of Knowledge, attitude, perceptions about clinical trials was given to 3^rd term medical students (n=115). With the help of Power point presentation the educational intervention was done. For statistical calculation, chi-square test and unpaired paired t-test were performed.
Results: are tabulated as percentages, Mean±SD. The scores pertaining to knowledge, attitude and perceptions of clinical trials were found to be statistically significant (P<0.001) when before (pre-KAP) and after (post-KAP) the educational intervention, was assessed.
Conclusion: The feedback from the students was encouraging, handouts supplied before the class made them to understand the subject better during lectures.

Keywords: Clinical trials, Continuous medical education, KAP questionnaire

How to cite : Deodurg P M, Bagewadi H G, Patil B, Dass A P, Knowledge, attitude & perceptions of 3rd term medical students towards clinical trials in a medical college in southern India. Indian J Pharm Pharmacol 2017;4(3):125-129

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.